Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
104.8 USD | +0.44% | +4.16% | -4.13% |
Apr. 30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
Apr. 30 | JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.13% | 12.93B | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
+0.49% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Transcript : PerkinElmer, Inc. Presents at KeyBanc Life Sciences & MedTech Investor Forum, Mar-21-2023 02